These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9009247)

  • 1. Extramedullary blast crisis in chronic myeloid leukemia.
    Specchia G; Palumbo G; Pastore D; Mininni D; Mestice A; Liso V
    Leuk Res; 1996; 20(11-12):905-8. PubMed ID: 9009247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interferon in the eradication of the Philadelphia chromosome in chronic myeloid leukemia].
    Arana-Trejo RM; Ovilla-Martínez R; Gómez-Morales E; Meillon-García L; Cervantes-Peredo A; González-Llaven J; Pizzuto-Chávez J; Kofman-Alfaro S
    Rev Invest Clin; 1997; 49(3):209-14. PubMed ID: 9380976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of chronic myelogenous leukemia in blast crisis and in accelerated phase with high- or intermediate-dose cytosine arabinoside and amsacrine.
    Bauduer F; Delmer A; Blanc MC; Delmas-Marsalet B; Cadiou M; Rio B; Marie JP; Zittoun R
    Leuk Lymphoma; 1993 Jun; 10(3):195-200. PubMed ID: 8220118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early lymphoid blastic crisis following major karyotypic conversion in a chronic myeloid leukemia patient treated with interferon-alpha.
    Ambrosetti A; Krampera M; Veneri D; Meneghini V; Aprili F; Martinelli G; Pizzolo G; Perona G
    Int J Clin Lab Res; 1994; 24(1):58-9. PubMed ID: 8180425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemotherapy of chronic myelogenous leukemia--VP(M) regimen initiated during its chronic phase, and evaluation of MCNU in the phase of blastic crisis].
    Kitajima K; Adachi T; Takahashi I; Nakada H; Osada K; Fukuda S; Ohmoto E; Aoyama S; Yorimitsu S; Sanada H
    Gan To Kagaku Ryoho; 1989 Nov; 16(11):3573-9. PubMed ID: 2817908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of accelerated and blastic phase of chronic myeloid leukemia with high-dose interferon alpha and hydroxyurea: a novel approach.
    Jehn U; Pötscher C; Heinemann V
    Leuk Lymphoma; 1995 Sep; 19(1-2):153-7. PubMed ID: 8574162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of chronic myelogenous leukemia in accelerated and blastic phases with daunorubicin, high-dose cytarabine, and granulocyte-macrophage colony-stimulating factor.
    Kantarjian HM; Talpaz M; Kontoyiannis D; Gutterman J; Keating MJ; Estey EH; O'Brien S; Rios MB; Beran M; Deisseroth A
    J Clin Oncol; 1992 Mar; 10(3):398-405. PubMed ID: 1740679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective single centre study of the outcome of five different therapy approaches in 48 patients with relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation.
    Elmaagacli AH; Beelen DW; Schaefer UW
    Bone Marrow Transplant; 1997 Dec; 20(12):1045-55. PubMed ID: 9466277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous hematopoietic stem cell transplantation in chronic myeloid leukemia with different clinical stages.
    Gopcsa L; Barta A; Banyai A; Foldi J; Kalasz L; Pajor L; Gidali J; Regeczy N; Paloczi K
    Acta Haematol; 2001; 106(3):100-5. PubMed ID: 11713374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of chronic myeloid leukaemia.
    Goldman JM
    Blood Rev; 1994 Mar; 8(1):21-9. PubMed ID: 8205007
    [No Abstract]   [Full Text] [Related]  

  • 11. Imatinib activity in vitro in tumor cells from patients with chronic myeloid leukemia in chronic phase and blast crisis.
    Olsson-Strömberg U; Aleskog A; Björnberg A; Höglund M; Simonsson B; Bengtsson M; Barbany G; Larsson R; Lindhagen E
    Anticancer Drugs; 2006 Jul; 17(6):631-9. PubMed ID: 16917208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up results of alpha interferon therapy in chronic myelogenous leukemia at M. D. Anderson Cancer Center.
    Kantarjian HM; Talpaz M
    Leuk Lymphoma; 1993; 11 Suppl 1():169-74. PubMed ID: 8251891
    [No Abstract]   [Full Text] [Related]  

  • 13. Bone marrow cytogenetic complete remission achieved by interferon-alpha plus cytarabine ocfosfate therapy in a patient with chronic myelogenous leukemia during extramedullary blast crisis.
    Gotoh A; Miyazawa K; Uchida Y; Sashida G; Kawakubo K; Kuriyama Y; Ohyashiki K
    Int J Hematol; 2002 Feb; 75(2):191-4. PubMed ID: 11939268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FLANG (fludarabine + cytosine arabinoside + novantrone + G-CSF) induces partial remission in lymphoid blast transformation of Ph+chronic myelogenous leukaemia.
    Martinelli G; Testoni N; Zuffa E; Visani G; Zinzani PL; Zaccaria A; Farabegoli P; Arpinati M; Amabile M; Tura S
    Leuk Lymphoma; 1996 Jun; 22(1-2):173-6. PubMed ID: 8724545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idarubicin in blastic crisis of chronic myelogenous leukemia.
    Lambertenghi-Deliliers G; Annaloro C; Cortellaro M; Pozzoli E; Oriani A; Polli EE
    Haematologica; 1991; 76(5):406-8. PubMed ID: 1806446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blast crisis of chronic myelogenous leukemia in long-lasting systemic lupus erythematosus: regression of both diseases after autologous bone marrow transplantation.
    Meloni G; Capria S; Vignetti M; Mandelli F; Modena V
    Blood; 1997 Jun; 89(12):4659. PubMed ID: 9192793
    [No Abstract]   [Full Text] [Related]  

  • 17. Donor buffy-coat infusion and chemotherapy for leukemia in relapse after marrow transplantation.
    Bogdanić V; Aurer I; Hitrec V; Boban D; Nemet D; Zupancić-Salek S; Labar B
    Haematologica; 1995; 80(4):338-40. PubMed ID: 7590504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive chemotherapy induction followed by interferon-alpha maintenance in patients with Philadelphia chromosome-positive chronic myelogenous leukemia.
    Kantarjian HM; Talpaz M; Keating MJ; Estey EH; O'Brien S; Beran M; McCredie KB; Gutterman J; Freireich EJ
    Cancer; 1991 Sep; 68(6):1201-7. PubMed ID: 1873771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic myeloid leukemia developing into a multifocal extramedullary blast crisis].
    Tapia M; García Zueco JC; Gómez Ara A; Lanau P; Giraldo P
    Sangre (Barc); 1997 Feb; 42(1):77-80. PubMed ID: 9229808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Extramedullary blast crisis in chronic myeloid leukemia].
    Cervantes F; Rozman M; Nicolás JM; López Guillermo A; Rozman C
    Sangre (Barc); 1989 Apr; 34(2):96-8. PubMed ID: 2756456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.